Comparison of reported and expected deaths in sildenafil (Viagra) users

https://doi.org/10.1016/S0002-9149(02)02342-1Get rights and content

Section snippets

Acknowledgements

We thank the members of the Viagra Working Group and others within the FDA who participated in discussions and analyses of these reports, and Joslyn Swann, RPh, who provided IMS HEALTH data. We also thank the physicians, pharmacists, other health care professionals, and consumers who reported these adverse events to the FDA.

First page preview

First page preview
Click to open first page preview

References (4)

There are more references available in the full text version of this article.

Cited by (0)

View full text